A lightweight and field-portable device invented at UCLA that conducts kidney tests and transmits data through a smartphone attachment may significantly reduce the need for frequent office visits by people with diabetes and others with chronic kidney ailments.
The smartphone-based device was developed in the research lab of Aydogan Ozcan, a professor of electrical engineering and bioengineering at the UCLA Henry Samueli School of Engineering and Applied Science, and associate director of the California NanoSystems Institute. Weighing about one-third of a pound, the gadget can determine levels of albumin in the patient’s urine and transmit the results within seconds. Albumin is a protein in blood that is a sign of danger when found in urine.
Ozcan’s lab also developed the opto-mechanical phone attachment, disposable test tubes, Android app and software to transmit the data. The research was published this month by the peer-reviewed journal Lab on a Chip.
“Albumin testing is frequently done to assess kidney damage, especially for diabetes patients,” Ozcan said. “This device provides an extremely convenient platform for chronic patients at home or in remote locations where cell phones work.”
Patients at risk for diabetes, kidney disease and other ailments must regularly provide fluid samples — sometimes more than one a day — to monitor their health, which requires visits to labs or health centers.
The new device projects beams of visible light through two small fluorescent tubes attached to the device, one containing a control liquid and the other a urine sample mixed with fluorescent dyes. The smartphone camera captures the fluorescent light after it passes through an additional lens.
An Android application then processes the raw images in less than one second and the device transmits the test results to a database or health care provider. The test, which measures albumin concentration in urine, is accurate to within less than 10 micrograms per milliliter, according to the research, well within accepted clinical standards used in diagnosing conditions such as microalbuminuria, the excretion of albumin in urine.
he time it takes to conduct a test, including preparation of a sample using a small syringe to inject the urine into a fluorescent tube, is about five minutes. Ozcan estimates that the device — for which his lab also has developed an iPhone app — could be produced commercially for $50 to $100 per unit.
The Latest on: Diagnosing disease
- New method enables accurate diagnosis of Alzheimer's disease on September 20, 2018 at 8:52 am
A new brain imaging method can show the spread of specific tau protein depositions, which are unique to cases with Alzheimer's. Diagnosing Alzheimer's disease can be difficult, as several other condit... […]
- A Brain Imaging Technique That's Better at Diagnosing Alzheimer's on September 20, 2018 at 7:41 am
Beta-amyloid is the other protein linked to Alzheimer’s disease. These study results are significant because they could be used to develop new drugs to stop the spread of tau proteins in the brain. Al... […]
- Alzheimer’s diagnosis might become simpler with new brain imaging method on September 19, 2018 at 10:41 pm
Accurate diagnosis of Alzheimer’s disease may be difficult in most patients as similar symptoms can be seen in several other disease conditions as well. Researchers have developed a new brain imaging ... […]
- Bolton's Darby forced to retire after Motor Neurone Disease diagnosis on September 19, 2018 at 7:27 pm
Bolton Wanderers defender Stephen Darby has been forced to retire aged 29 after being diagnosed with Motor Neurone Disease. The former Liverpool youth academy product joined Bolton from Bradford ... […]
- Tau PET agent accurately diagnosis Alzheimer’s from other neurodegenerative diseases on September 19, 2018 at 2:53 pm
In patients with diagnosed Alzheimer’s disease (AD), [18F] flortaucipir PET imaging proved accurate in distinguishing AD from other neurodegenerative diseases, according to a multicenter study publish... […]
- Diagnosing and Treating Infectious Diseases with Nuclear Techniques on September 19, 2018 at 8:37 am
Every year, 13 million people die from infectious diseases such as tuberculosis, malaria and HIV/AIDS around the world. The overwhelming majority of these deaths occur in developing countries and earl... […]
- Tau PET Tracer Called Accurate for Alzheimer's Diagnosis on September 18, 2018 at 4:22 pm
The clinical diagnosis served as reference standard because there was ... et al “Discriminative accuracy of 18F flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerati... […]
- AI improves doctors' ability to correctly interpret tests and diagnose lung disease on September 18, 2018 at 4:16 pm
Artificial intelligence (AI) can be an invaluable aid to help lung doctors interpret respiratory symptoms accurately and make a correct diagnosis, according to new research. Artificial intelligence (A... […]
- Bolton Defender Stephen Darby Retires at 29 Due to Motor Neurone Disease Diagnosis on September 18, 2018 at 7:57 am
Bolton defender Stephen Darby has been forced to retire from professional football at the age of 29 after he was diagnosed with Motor Neurone Disease. Darby, who joined Bolton in the summer of 2017, r... […]
- Bolton defender Darby diagnosed with motor neurone disease on September 18, 2018 at 5:42 am
(Reuters) - Bolton Wanderers defender Stephen Darby has retired from football after being diagnosed with motor neurone disease, his club said on Tuesday. Darby, who began his career at his hometown si... […]
via Google News and Bing News